02.10.2017 • News

Praxair Shareholders Approve Merger with Linde

(c) Linde
(c) Linde

Praxair’s shareholders have overwhelmingly approved the proposed merger with Linde. At a special shareholders meeting on Sept. 27, about 83% of the total issued and outstanding shares of Praxair common stock was in favor of the deal, exceeding the required majority and representing approximately 99% of the total votes cast.

“Today’s vote confirms that Praxair shareholders support this transaction and brings us one step closer to creating a world-class leader in the industrial gas industry,” said Steve Angel, Praxair’s chairman and CEO.

The approval is an essential step toward combining the two major industrial gases group under new holding company, Linde plc. However, 75% of Linde’s shareholders must tender their stock to the new company by Oct. 24 for the merger to go ahead, as well as obtaining antitrust approvals and fulfilling other customary closing conditions.

Praxair and Linde expect the transaction to complete in the second half of 2018.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

most read